The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Disprin Extra Strength 500 mg Effervescent tablets



Reckitt Benckiser Ireland LtdPA0979/006/002

Main Information

Trade NameDisprin Extra Strength 500 mg Effervescent tablets
Active SubstancesAcetylsalicylic acid
Dosage FormEffervescent tablet
Licence HolderReckitt Benckiser Ireland Ltd
Licence NumberPA0979/006/002

Group Information

ATC CodeN02BA Salicylic acid and derivatives
N02BA01 acetylsalicylic acid

Status

Authorised/WithdrawnAuthorised
Licence Issued18/09/1998
Legal statusProduct not subject to medical prescription
Supply StatusSupply through non-pharmacy outlets and pharmacies
Advertising StatusAdvertising to the general public
Conditions of LicenceGeneral sale in blister packs containing not more than 16 unit dosage forms. Retail sale through pharmacies only in blister packs containing not more than 24 unit dosage forms The indications should be appropriate for self-diagnosis and self-treatment. Promotion to the general public only for indications appropriate for self-diagnosis and self-treatment. Aspirin-containing medicinal products should not be administered to subjects under 16 years of age unless specifically indicated by a healthcare professional. Maximum pack size 16
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back